Biological Background: LAMTOR4 and the Ragulator Complex

LAMTOR4 (Late Endosomal/Lysosomal Adaptor and MAPK and mTOR Activator 4), encoded by the C7orf59 gene, is a subunit of the pentameric Ragulator complex. The Ragulator complex, composed of LAMTOR1–5 (also designated p18, p14, MP1, C7orf59, and HBXIP respectively), localizes to the cytoplasmic face of late endosomes and lysosomes via the N-terminal lipid modifications of LAMTOR1.

The Ragulator complex serves two essential functions: it anchors the entire Rag GTPase heterodimer (RagA/B with RagC/D) to the lysosomal surface and acts as a guanine nucleotide exchange factor (GEF) for RagA/B. Amino acid sufficiency triggers lysosomal v-ATPase to activate the Ragulator–Rag axis, which in turn recruits mTOR complex 1 (mTORC1) to the lysosomal membrane where it is activated by the small GTPase Rheb. LAMTOR4 contributes to the structural integrity of this scaffold, and loss-of-function perturbations impair mTORC1 activation and promote autophagy induction under nutrient-replete conditions.

Beyond mTORC1 regulation, the Ragulator complex participates in MAPK pathway modulation, lysosomal biogenesis, and immune cell function, making LAMTOR4 a protein of broad relevance across cell biology and disease research.

Recombinant Protein Production and Quality Considerations

Recombinant Human LAMTOR4 Protein (SKU: rp373292) is produced using established recombinant expression systems to ensure batch-to-batch consistency in structure and activity. When evaluating a recombinant LAMTOR4 preparation, researchers should consider the following quality attributes:

• Purity: High-purity preparations (typically ≥85–95% by SDS-PAGE) minimize off-target effects in functional assays. Confirm purity by reducing SDS-PAGE and, where available, by size-exclusion chromatography.
• Tag and cleavage: Affinity tags (His, GST, or MBP) facilitate purification but may influence protein–protein interaction studies. Verify whether the tag has been removed prior to use in co-immunoprecipitation or pull-down experiments.
• Endotoxin levels: For cell-based assays, confirm that endotoxin content is within acceptable limits (typically <1.0 EU/µg) to avoid non-specific innate immune activation.
• Formulation and storage: Recombinant proteins are commonly supplied lyophilized or in aqueous buffer containing carrier protein (e.g., BSA) or glycerol as a cryoprotectant. Aliquot upon reconstitution and avoid repeated freeze–thaw cycles to preserve activity.

Researchers requiring confirmation of biological activity should consider functional assays such as Ragulator complex reconstitution pull-downs, surface plasmon resonance (SPR) binding studies with Rag GTPases, or mTORC1 activity assays in cell-free systems.

Research Applications of LAMTOR4 Protein

Recombinant Human LAMTOR4 Protein is used across a range of in vitro and biochemical research applications:

• mTORC1 signaling studies: LAMTOR4 is employed in reconstitution experiments to study the assembly and GEF activity of the Ragulator complex toward RagA/B GTPases, providing mechanistic insight into amino acid–dependent mTORC1 activation.
• Protein–protein interaction (PPI) analysis: Pull-down assays, co-immunoprecipitation, and yeast two-hybrid approaches utilize recombinant LAMTOR4 to map binding interfaces within the Ragulator complex (LAMTOR1–5) and with Rag GTPase heterodimers.
• Structural biology: Recombinant LAMTOR4 is used in cryo-EM and X-ray crystallography studies aimed at resolving the architecture of the Ragulator–Rag supercomplex on the lysosomal surface.
• Antibody development and validation: Purified recombinant protein serves as an antigen for generating monoclonal or polyclonal antibodies and as a positive control for Western blot, ELISA, and immunofluorescence assay validation.
• Autophagy and nutrient signaling research: LAMTOR4 perturbation models (knockdown, knockout, dominant-negative) paired with recombinant rescue protein are used to dissect the role of Ragulator in autophagy flux under starvation and re-feeding conditions.
• Immunology: Emerging data implicate Ragulator/LAMTOR proteins in dendritic cell and T-cell activation; recombinant LAMTOR4 supports mechanistic studies in innate and adaptive immunity.

Handling, Storage, and Reconstitution Protocol

Proper handling of recombinant proteins is essential to maintain activity and reproducibility. Follow these general guidelines for Recombinant Human LAMTOR4 Protein:

1. Receipt and inspection: Upon receipt, verify the lot number, inspect packaging integrity, and confirm that the product has remained at the appropriate shipping temperature. Log receipt date.
2. Short-term storage: If the protein will be used within 1–2 weeks, store at 4 °C in the supplied buffer. Avoid repeated temperature fluctuations.
3. Long-term storage: For storage beyond two weeks, aliquot into single-use volumes and store at −20 °C or −80 °C (preferred). Addition of a carrier protein such as 0.1% BSA may improve stability during freeze–thaw cycles if not already present in the formulation.
4. Reconstitution (lyophilized format): Centrifuge the vial briefly before opening. Reconstitute in sterile, ultrapure water or the buffer specified in the product datasheet to the recommended concentration. Allow the protein to dissolve at 4 °C with gentle rotation; avoid vortexing.
5. Working concentration: Determine the optimal working concentration empirically for each assay type. As a general starting point, 0.1–1.0 µg per reaction is typical for pull-down and binding studies, but titration is recommended.
6. Avoid freeze–thaw cycles: Repeated freeze–thaw cycles degrade protein integrity. Single-use aliquots are strongly recommended.

Always refer to the product-specific datasheet supplied with each lot for precise buffer composition, concentration, and any lot-specific quality control data.

LAMTOR4 in Disease and Translational Relevance

Dysregulation of the mTORC1 pathway, in which LAMTOR4 plays an integral scaffolding role, is implicated in a wide spectrum of human diseases. Understanding LAMTOR4 function therefore holds translational significance:

• Cancer: Aberrant mTORC1 hyperactivation is a hallmark of many cancers, including breast, renal cell carcinoma, and glioblastoma. Components of the Ragulator complex, including LAMTOR4, represent potential nodes for therapeutic intervention upstream of mTORC1.
• Metabolic disorders: mTORC1-driven regulation of lipid synthesis, mitochondrial biogenesis, and protein translation places Ragulator complex subunits in the context of obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) research.
• Neurodegeneration: Impaired lysosomal function and mTORC1 dysregulation are observed in Alzheimer's disease and Parkinson's disease models. LAMTOR4 research may contribute to understanding lysosomal dysfunction in these contexts.
• Immunodeficiency: Mutations in LAMTOR2 have been linked to primary immunodeficiency syndromes, raising the possibility that other Ragulator subunits, including LAMTOR4, may have immunological roles relevant to human disease.
• Rare lysosomal storage disorders: The intersection of lysosomal membrane biology and mTOR signaling creates potential links between Ragulator dysfunction and lysosomal storage diseases, an area of ongoing investigation.

Recombinant Human LAMTOR4 Protein supports basic and translational research efforts in all of these areas by enabling mechanistic dissection of Ragulator function in relevant disease models.